Thomas J. Gardner
Papers
1
Total Citations
27
H-Index
1
About
Dr. Thomas J. Gardner is a leading virologist whose research centers on human cytomegalovirus (CMV) biology, with a particular focus on viral entry mechanisms and the development of novel therapeutic strategies. His most cited work, "Functional screening for anti-CMV biologics identifies a broadly neutralizing epitope of an essential envelope protein" (2016, 27 citations), represents a significant breakthrough in the field. In this landmark study, Gardner and his team identified a critical, broadly neutralizing epitope on the CMV gH/gL/gO trimer complex—an essential envelope protein required for viral entry into all cell types. This discovery not only illuminated a key vulnerability in the CMV life cycle but also provided a promising target for antibody-based therapeutics. By demonstrating that antibodies targeting this epitope could neutralize a wide range of CMV strains, Gardner's work has opened new avenues for vaccine design and passive immunotherapy. His contributions are particularly impactful given CMV's status as a leading cause of birth defects and a major threat to immunocompromised patients, making his research both scientifically rigorous and clinically relevant.
Research Focus
Key Achievements
Top Papers
- 1